Search Results - "De la Torre Hernandez, Jose"

Transcatheter versus surgical aortic valve replacement in patients with morbid obesity: a multicentre propensity score-matched analysis by McInerney, Angela, Rodés-Cabau, Josep, Veiga, Gabriela, López-Otero, Diego, Muñoz-García, Erika, Campelo-Parada, Francisco, Oteo, Juan F, Carnero, Manuel, Tafur Soto, José D, Amat-Santos, Ignacio J, Travieso, Alejandro, Mohammadi, Siamak, Barbanti, Marco, Cheema, Asim N, Toggweiler, Stefan, Saia, Francesco, Dabrowski, Maciej, Serra, Vicenç, Alfonso, Fernando, Ribeiro, Henrique B, Regueiro, Ander, Alpieri, Alberto, Gil Ongay, Aritz, Martinez-Cereijo, Jose M, Muñoz-García, Antonio, Matta, Anthony, Arellano Serrano, Carlos, Barrero, Alejandro, Tirado-Conte, Gabriela, Gonzalo, Nieves, Sanmartin, Xoan C, de la Torre Hernandez, Jose M, Kalavrouziotis, Dimitri, Maroto, Luis, Forteza-Gil, Alberto, Cobiella, Javier, Escaned, Javier, Nombela-Franco, Luis

“…Morbidly obese (MO) patients are increasingly undergoing transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR) for severe…”
Get full text

A multi-center, international, randomized, 2-year, parallel-group study to assess the superiority of IVUS-guided PCI versus qualitative angio-guided PCI in unprotected left main coronary artery (ULMCA) disease: Study protocol for OPTIMAL trial by De Maria, Giovanni Luigi, Testa, Luca, de la Torre Hernandez, Jose M, Terentes-Printzios, Dimitrios, Emfietzoglou, Maria, Scarsini, Roberto, Bedogni, Francesco, Spitzer, Ernest, Banning, Adrian

“…Percutaneous coronary intervention (PCI) is used increasingly for revascularization of unprotected left main coronary artery (LMCA) disease. Observational…”
Get full text

Duration of Dual Antiplatelet Therapy for Patients at High Bleeding Risk Undergoing PCI by Valgimigli, Marco, Cao, Davide, Angiolillo, Dominick J., Bangalore, Sripal, Bhatt, Deepak L., Ge, Junbo, Hermiller, James, Makkar, Raj R., Neumann, Franz-Josef, Saito, Shigeru, Picon, Hector, Toelg, Ralph, Maksoud, Aziz, Chehab, Bassem M., Choi, James W., Campo, Gianluca, De la Torre Hernandez, Jose M., Kunadian, Vijay, Sardella, Gennaro, Thiele, Holger, Varenne, Olivier, Vranckx, Pascal, Windecker, Stephan, Zhou, Yujie, Krucoff, Mitchell W., Ruster, Karine, Zheng, Yan, Mehran, Roxana

“…The optimal duration of dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) among patients at high bleeding risk (HBR) is unknown…”
Get full text

A Mechanical Approach for Smooth Surface Fitting to Delineate Vessel Walls in Optical Coherence Tomography Images by Olender, Max L., Athanasiou, Lambros S., de la Torre Hernandez, Jose M., Ben-Assa, Eyal, Nezami, Farhad Rikhtegar, Edelman, Elazer R.

“…Automated analysis of vascular imaging techniques is limited by the inability to precisely determine arterial borders. Intravascular optical coherence…”
Get full text

Outcomes Prediction in Complex High-Risk Indicated Percutaneous Coronary Interventions in the Older Patients by Marschall, Alexander, Martí Sánchez, David, Ferreiro, José Luis, Lopez Palop, Ramon, Ojeda, Soledad, Avanzas, Pablo, Jimenez Mazuecos, Jesus M., Carrillo Sáez, Pilar, Gutierrez-Barrios, Alejandro, de la Torre Hernandez, Jose M.

“…Complex high-risk indicated percutaneous coronary intervention (CHIP-PCI) is a poorly defined concept, which has not been validated in an older population…”
Get full text

One-Month Versus Three-Month Dual-Antiplatelet Therapy in High Bleeding Risk Patients With Chronic Kidney Disease by Mankerious, Nader, Toelg, Ralph, Vogel, Birgit, Sartori, Samantha, Angiolillo, Dominick J., Vranckx, Pascal, Feng, Yihan, de la Torre Hernandez, Jose M., Krucoff, Mitchell W., Bhatt, Deepak L., Spirito, Alessandro, Cao, Davide, Chehab, Bassem M., Kunadian, Vijay, Maksoud, Aziz, Picon, Hector, Sardella, Gennaro, Thiele, Holger, Varenne, Olivier, Windecker, Stephan, Richardt, Gert, Valgimigli, Marco, Mehran, Roxana

“…•High bleeding risk patients receiving cobalt-chromium everolimus-eluting stents were enrolled.•Chronic kidney disease (CKD) was highly prevalent.•CKD patients…”
Get full text

Early healing assessment with optical coherence tomography of everolimus-eluting stents with bioabsorbable polymer (synergy™) at 3 and 6 months after implantation by de la Torre Hernández, Jose M., Tejedor, Paula, Camarero, Tamara Garcia, Duran, Juan M., Lee, Dae-Hyun, Monedero, Jairo, Laso, Fermin Sainz, Calderón, Marcos Alvarez, Veiga, Gabriela, Zueco, Javier

“…Objectives In this study we sought to evaluate coverage and apposition of Synergy™ stent at 3 and 6 months after implantation. Background The Pt‐Cr…”
Get full text

Individual Patient Data Meta-analysis of Drug-eluting Versus Bare-metal Stents for Percutaneous Coronary Intervention in Chronic Versus Acute Coronary Syndromes by Piccolo, Raffaele, Bonaa, Kaare H., Efthimiou, Orestis, Varenne, Olivier, Baldo, Andrea, Urban, Philip, Kaiser, Christoph, de Belder, Adam, Lemos, Pedro A., Wilsgaard, Tom, Reifart, Jörg, Ribeiro, Expedito E., Serruys, Patrick WJC, Byrne, Robert A., de la Torre Hernandez, Jose M., Esposito, Giovanni, Wijns, William, Jüni, Peter, Windecker, Stephan, Valgimigli, Marco

“…New-generation drug-eluting stents (DES) strongly reduce restenosis and repeat revascularization compared with bare-metal stents (BMS) for percutaneous…”
Get full text

Outcomes of 10,312 patients treated with everolimus‐eluting bioresorbable scaffolds during daily clinical practice – results from the European Absorb Consortium by Wiebe, Jens, Hofmann, Felix J., West, Nick, Baumbach, Andreas, Carrie, Didier, Bermudez, Eduardo Pinar, Cayla, Guillaume, Hernandez, Felipe Hernandez, Torre Hernandez, Jose M., Koning, René, Loi, Bruno, Moscarella, Elisabetta, Tarantini, Giuseppe, Zaman, Azfar, Lober, Christiane, Riemer, Thomas, Achenbach, Stephan, Hamm, Christian W., Nef, Holger M.

“…Objectives To asses mid‐term clinical outcomes of bioresorbable vascular scaffolds (BVS) for the treatment of coronary artery disease in a large‐scale…”
Get full text

A Prospective Randomized Trial of Everolimus-Eluting Stents Versus Bare-Metal Stents in Octogenarians by de Belder, Adam, MD, de la Torre Hernandez, Jose M., MD, PhD, Lopez-Palop, Ramon, PhD, O'Kane, Peter, MD, Hernandez Hernandez, Felipe, MD, Strange, Julian, MD, Gimeno, Federico, PhD, Cotton, James, MD, Diaz Fernandez, Jose F., MD, Carrillo Saez, Pilar, PhD, Thomas, Martyn, MD, Pinar, Eduardo, PhD, Curzen, Nick, PhD, Baz, Jose A., MD, Cooter, Nina, RCN, Lozano, Inigo, PhD, Skipper, Nicola, RCN, Robinson, Derek, PhD, Hildick-Smith, David, MD

“…Objectives The aim of this study was to determine whether drug-eluting stents (DES) are superior to bare-metal stents (BMS) in octogenarian patients with…”
Get full text

Intraprocedural delayed reassessment of paravalvular regurgitation in TAVR significantly reduces the use of postdilatation by De la Torre Hernandez, Jose M., Veiga Fernandez, Gabriela, Barrera, Sergio, Sainz Laso, Fermin, Lee, Dae‐Hyun, Ruisanchez Villar, Cristina, Lerena, Piedad, Garcia Camarero, Tamara, Cuesta Cosgaya, Jose M., Gil Ongay, Aritz, Zueco, Javier

“…Objectives We sought to investigate the effect of a 15‐min delayed intraprocedural reassessment of paravalvular aortic regurgitation (PVR) after an immediate…”
Get full text

Clinical use of intracoronary imaging. Part 1: guidance and optimization of coronary interventions. An expert consensus document of the European Association of Percutaneous Cardiovascular Interventions by Räber, Lorenz, Mintz, Gary S, Koskinas, Konstantinos C, Johnson, Thomas W, Holm, Niels R, Onuma, Yoshinubo, Radu, Maria D, Joner, Michael, Yu, Bo, Jia, Haibo, Meneveau, Nicolas, de la Torre Hernandez, Jose M, Escaned, Javier, Hill, Jonathan, Prati, Francesco, Colombo, Antonio, di Mario, Carlo, Regar, Evelyn, Capodanno, Davide, Wijns, William, Byrne, Robert A, Guagliumi, Giulio

“…Abstract This Consensus Document is the first of two reports summarizing the views of an expert panel organized by the European Association of Percutaneous…”
Get full text

Clinical use of intracoronary imaging. Part 2: acute coronary syndromes, ambiguous coronary angiography findings, and guiding interventional decision-making: an expert consensus document of the European Association of Percutaneous Cardiovascular Interventions by Johnson, Thomas W, Räber, Lorenz, di Mario, Carlo, Bourantas, Christos, Jia, Haibo, Mattesini, Alessio, Gonzalo, Nieves, de la Torre Hernandez, Jose M, Prati, Francesco, Koskinas, Konstantinos, Joner, Michael, Radu, Maria D, Erlinge, David, Regar, Evelyn, Kunadian, Vijay, Maehara, Akiko, Byrne, Robert A, Capodanno, Davide, Akasaka, Takashi, Wijns, William, Mintz, Gary S, Guagliumi, Giulio

“…Abstract This consensus document is the second of two reports summarizing the views of an expert panel organized by the European Association of Percutaneous…”
Get full text

Drug-eluting or bare-metal stents for percutaneous coronary intervention: a systematic review and individual patient data meta-analysis of randomised clinical trials by Piccolo, Raffaele, Bonaa, Kaare H, Efthimiou, Orestis, Varenne, Olivier, Baldo, Andrea, Urban, Philip, Kaiser, Christoph, Remkes, Wouter, Räber, Lorenz, de Belder, Adam, van 't Hof, Arnoud W J, Stankovic, Goran, Lemos, Pedro A, Wilsgaard, Tom, Reifart, Jörg, Rodriguez, Alfredo E, Ribeiro, Expedito E, Serruys, Patrick W J C, Abizaid, Alex, Sabaté, Manel, Byrne, Robert A, de la Torre Hernandez, Jose M, Wijns, William, Jüni, Peter, Windecker, Stephan, Valgimigli, Marco, Piccolo, Raffaele, Bonaa, Kaare H., Efthimiou, Orestis, Varenne, Olivier, Baldo, Andrea, Urban, Philip, Kaiser, Christoph, Remkes, Wouter, Räber, Lorenz, de Belder, Adam, van't Hof, Arnoud W.J., Stankovic, Goran, Lemos, Pedro A., Wilsgaard, Tom, Reifart, Jörg, Rodriguez, Alfredo E., Ribeiro, Expedito E., Serruys, Patrick W.J.C., Abizaid, Alex, Sabaté, Manel, Byrne, Robert A., de la Torre Hernandez, Jose M., Wijns, William, Jüni, Peter, Windecker, Stephan, Valgimigli, Marco

“…New-generation drug-eluting stents (DES) have mostly been investigated in head-to-head non-inferiority trials against early-generation DES and have typically…”
Get full text

Sirolimus‐coated balloon versus everolimus‐eluting stent in de novo coronary artery disease: Rationale and design of the TRANSFORM II randomized clinical trial by Greco, Antonio, Sciahbasi, Alessandro, Abizaid, Alexandre, Mehran, Roxana, Rigattieri, Stefano, Torre Hernandez, Jose M., Alfonso, Fernando, Cortese, Bernardo

“…Background Percutaneous coronary intervention (PCI) with drug‐eluting stent (DES) implantation is a widely adopted strategy for the treatment of de novo…”
Get full text

First description and validation of a new method for estimating aortic stenosis burden and predicting the functional response to TAVI by de la Torre Hernandez, Jose M., Veiga Fernandez, Gabriela, Ben-Assa, Eyal, Iribarren, Julia, Sainz Laso, Fermin, Lee, Dae-Hyun, Ruisanchez Villar, Cristina, Lerena, Piedad, Garcia Camarero, Tamara, Iribarren Sarrias, Jose L., Cuesta Cosgaya, Jose M., Maza Fernandez, Maria E., Garilleti, Celia, Fradejas-Sastre, Victor, Benito, Mercedes, Barrera, Sergio, Gil Ongay, Aritz, Vazquez de Prada, Jose A., Zueco, Javier

“…Background Up to one-fifth of patients continue to have poor quality of life after transcatheter aortic valve implantation (TAVI), with an additional similar…”
Get full text

Implementation of Institutional Protocols for Patients With Acute Coronary Syndrome: Nonclinical Factors Also Matter by Lozano, Iñigo, Sanchez Perez, Andres, Sanchez-Insa, Esther, Mechan, Juan Carlos Rama, Gopar, Silvia, Ruiz-Quevedo, Valeriano, Fernandez Fernandez, Javier, Gomez-Jaume, Alfredo, Bayon, Jeremias, Lasa, Garikoitz, Fernandez-Portales, Javier, Hernandez, Jose M. de la Torre, Mañas, Pilar, Pinar, Eduardo, Lopez-Palop, Ramon, Albarran, Agustin, de Leiras, Sergio Rodriguez

Get full text

3- or 1-Month DAPT in Patients at High Bleeding Risk Undergoing Everolimus-Eluting Stent Implantation by Mehran, Roxana, Cao, Davide, Angiolillo, Dominick J., Bangalore, Sripal, Bhatt, Deepak L., Ge, Junbo, Hermiller, James, Makkar, Raj R., Neumann, Franz-Josef, Saito, Shigeru, Picon, Hector, Toelg, Ralph, Maksoud, Aziz, Chehab, Bassem M., De la Torre Hernandez, Jose M., Kunadian, Vijay, Sardella, Gennaro, Thiele, Holger, Varenne, Olivier, Vranckx, Pascal, Windecker, Stephan, Zhou, Yujie, Krucoff, Mitchell W., Ruster, Karine, Wang, Jin, Valgimigli, Marco

“…The aim of this study was to evaluate 2 abbreviated dual-antiplatelet therapy (DAPT) regimens in patients at high bleeding risk (HBR) undergoing percutaneous…”
Get full text

A new integrative approach to assess aortic stenosis burden and predict objective functional improvement after TAVR by de la Torre Hernandez, Jose M, Veiga Fernandez, Gabriela, Ben-Assa, Eyal, Sainz Laso, Fermin, Lee, Dae-Hyun, Ruisanchez Villar, Cristina, Lerena, Piedad, Garcia Camarero, Tamara, Cuesta Cosgaya, Jose M, Fradejas-Sastre, Victor, Benito, Mercedes, Barrera, Sergio, Garcia-Unzueta, Maria T, Brown, Jonathan, Gil Ongay, Aritz, Zueco, Javier, Vazquez de Prada, Jose A, Edelman, Elazer R

“…A non-negligible rate of patients undergoing transcatheter aortic valve replacement (TAVR) do not report symptomatic improvement or even die in the…”
Get full text

Optical coherence tomography, intravascular ultrasound or angiography guidance for distal left main coronary stenting. The ROCK cohort II study by Cortese, Bernardo, Torre Hernandez, Jose M., Lanocha, Magdalena, Ielasi, Alfonso, Giannini, Francesco, Campo, Gianluca, D'Ascenzo, Fabrizio, Latini, Roberto A., Krestianinov, Oleg, Alfonso, Fernando, Trani, Carlo, Prati, Francesco, Linares, Jose A., Sardella, Gennaro, Wlodarczak, Adrian, Viganò, Elena, Camarero, Tamara Garcia, Stella, Pieter, Sozykin, Alexander, Fineschi, Massimo, Burzotta, Francesco

“…Objectives to test the safety and efficacy of intravascular imaging and specifically optical coherence tomography (OCT) as a diagnostic tool for left main…”
Get full text